Literature DB >> 9242172

An adjustment to the 1997 estimate for new prostate cancer cases.

P A Wingo1, S Landis, L A Ries.   

Abstract

Entities:  

Mesh:

Year:  1997        PMID: 9242172     DOI: 10.3322/canjclin.47.4.239

Source DB:  PubMed          Journal:  CA Cancer J Clin        ISSN: 0007-9235            Impact factor:   508.702


× No keyword cloud information.
  7 in total

1.  Prostate carcinoma: clarification through clinical insight and molecular diagnostics.

Authors:  F J Meyers; R W DeVere White
Journal:  West J Med       Date:  1998-06

Review 2.  Male circumcision and prostate cancer: A geographical analysis, meta-analysis, and cost analysis.

Authors:  Robert S Van Howe
Journal:  Can Urol Assoc J       Date:  2020-07       Impact factor: 1.862

3.  Silibinin decreases prostate-specific antigen with cell growth inhibition via G1 arrest, leading to differentiation of prostate carcinoma cells: implications for prostate cancer intervention.

Authors:  X Zi; R Agarwal
Journal:  Proc Natl Acad Sci U S A       Date:  1999-06-22       Impact factor: 11.205

Review 4.  [Treatment options for hormone-refractory prostate cancer].

Authors:  A Heidenreich; C H Ohlmann
Journal:  Urologe A       Date:  2005-11       Impact factor: 0.639

5.  Bioimpedance and chronoamperometry as an adjunct to prostate-specific antigen screening for prostate cancer.

Authors:  Darci Schiavon de Abreu
Journal:  Cancer Manag Res       Date:  2011-04-21       Impact factor: 3.989

6.  Controversies in the management of advanced prostate cancer.

Authors:  C J Tyrrell
Journal:  Br J Cancer       Date:  1999-01       Impact factor: 7.640

7.  Bone morphogenetic protein 6 in skeletal metastases from prostate cancer and other common human malignancies.

Authors:  P Autzen; C N Robson; A Bjartell; A J Malcolm; M I Johnson; D E Neal; F C Hamdy
Journal:  Br J Cancer       Date:  1998-11       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.